{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:00:34Z","timestamp":1784966434267,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T32DK007260-47"],"award-info":[{"award-number":["5T32DK007260-47"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01582-y","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T07:09:14Z","timestamp":1784963354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Teriparatide Therapy in Children with Hypoparathyroidism: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-662X","authenticated-orcid":false,"given":"Nessa","family":"Tantivit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5148-703X","authenticated-orcid":false,"given":"Siwakorn","family":"Punyawatthananukool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"18","key":"1582_CR1","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","volume":"380","author":"RI Gafni","year":"2019","unstructured":"Gafni RI, Collins MT (2019) Hypoparathyroidism. N Engl J Med 380(18):1738\u20131747. https:\/\/doi.org\/10.1056\/NEJMcp1800213","journal-title":"N Engl J Med"},{"issue":"3","key":"1582_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jbmr.3329","volume":"33","author":"T Vadiveloo","year":"2018","unstructured":"Vadiveloo T, Donnan PT, Leese GP (2018) A population-based study of the epidemiology of chronic hypoparathyroidism. J Bone Miner Res 33(3):478\u2013485. https:\/\/doi.org\/10.1002\/jbmr.3329","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1582_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/jc.2015-3908","volume":"101","author":"BL Clarke","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT et al (2016) Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab 101(6):2284\u20132299. https:\/\/doi.org\/10.1210\/jc.2015-3908","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1582_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/jbmr.3854","volume":"34","author":"Y Wang","year":"2019","unstructured":"Wang Y, Nie M, Wang O et al (2019) Genetic screening in a large Chinese cohort of childhood onset hypoparathyroidism by next-generation sequencing combined with TBX1 -MLPA. J Bone Miner Res 34(12):2254\u20132263. https:\/\/doi.org\/10.1002\/jbmr.3854","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1582_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/cen.12944","volume":"83","author":"JH Kim","year":"2015","unstructured":"Kim JH, Shin Y, Yang S et al (2015) Diverse genetic aetiologies and clinical outcomes of paediatric hypoparathyroidism. Clin Endocrinol (Oxf) 83(6):790\u2013796. https:\/\/doi.org\/10.1111\/cen.12944","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"1582_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1089\/thy.2017.0309","volume":"28","author":"LA Orloff","year":"2018","unstructured":"Orloff LA, Wiseman SM, Bernet VJ et al (2018) American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid 28(7):830\u2013841. https:\/\/doi.org\/10.1089\/thy.2017.0309","journal-title":"Thyroid"},{"issue":"4","key":"1582_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1210\/jc.2018-02228","volume":"104","author":"S Saha","year":"2019","unstructured":"Saha S, Goswami R (2019) Auditing the efficacy and safety of alfacalcidol and calcium therapy in idiopathic hypoparathyroidism. J Clin Endocrinol Metab 104(4):1325\u20131335. https:\/\/doi.org\/10.1210\/jc.2018-02228","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1582_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1172\/JCI100224","volume":"7","author":"F Albright","year":"1929","unstructured":"Albright F, Ellsworth R (1929) Studies on the physiology of the parathyroid glands: I. Calcium and phosphorus studies in a case of idiopathic hypoparathyroidism. J Clin Invest 7(2):183\u2013201","journal-title":"J Clin Invest"},{"key":"1582_CR9","doi-asserted-by":"publisher","first-page":"1615712","DOI":"10.3389\/fendo.2025.1615712","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Hu H, Huang Y (2025) Advances in the application of bone turnover markers for pediatric growth and developmental disorders: a review. Front Endocrinol 16:1615712. https:\/\/doi.org\/10.3389\/fendo.2025.1615712","journal-title":"Front Endocrinol"},{"issue":"11","key":"1582_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jbmr\/zjaf118","volume":"40","author":"AL Bonnet","year":"2025","unstructured":"Bonnet AL, Aboishava L, Mannstadt M (2025) Advances in parathyroid hormone-based medicines. J Bone Miner Res 40(11):1195\u20131206. https:\/\/doi.org\/10.1093\/jbmr\/zjaf118","journal-title":"J Bone Miner Res"},{"key":"1582_CR11","doi-asserted-by":"publisher","first-page":"156335","DOI":"10.1016\/j.metabol.2025.156335","volume":"171","author":"AA Khan","year":"2025","unstructured":"Khan AA, Ali DS, Bilezikian JP et al (2025) Best practice recommendations for the diagnosis and management of hypoparathyroidism. Metabolism 171:156335. https:\/\/doi.org\/10.1016\/j.metabol.2025.156335","journal-title":"Metabolism"},{"issue":"1","key":"1582_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11914-025-00905-6","volume":"23","author":"A Palermo","year":"2025","unstructured":"Palermo A, Naciu AM, Donovan YKT, Tabacco G, Zavatta G (2025) PTH substitution therapy for chronic hypoparathyroidism: PTH 1\u201384 and palopegteriparatide. Curr Osteoporos Rep 23(1):12. https:\/\/doi.org\/10.1007\/s11914-025-00905-6","journal-title":"Curr Osteoporos Rep"},{"issue":"9","key":"1582_CR13","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-2552","volume":"93","author":"KK Winer","year":"2008","unstructured":"Winer KK, Sinaii N, Peterson D, Sainz B, Cutler GB (2008) Effects of once versus twice-daily parathyroid hormone 1\u201334 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93(9):3389\u20133395. https:\/\/doi.org\/10.1210\/jc.2007-2552","journal-title":"J Clin Endocrinol Metab"},{"key":"1582_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","volume":"165","author":"KK Winer","year":"2015","unstructured":"Winer KK, Fulton K, Albert P, Cutler GB Jr, Shriver EK (2015) Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1\u201334 in children with severe congenital hypoparathyroidism. J Paediatr 165:556\u2013563","journal-title":"J Paediatr"},{"issue":"6","key":"1582_CR15","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1210\/jc.2009-2464","volume":"95","author":"KK Winer","year":"2010","unstructured":"Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB (2010) Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab 95(6):2680\u20132688. https:\/\/doi.org\/10.1210\/jc.2009-2464","journal-title":"J Clin Endocrinol Metab"},{"key":"1582_CR16","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2013-0159","author":"P Matarazzo","year":"2014","unstructured":"Matarazzo P, Tuli G, Fiore L et al (2014) Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism. J Pediatr Endocrinol Metab. https:\/\/doi.org\/10.1515\/jpem-2013-0159","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1582_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jpeds.2018.08.010","volume":"203","author":"KK Winer","year":"2018","unstructured":"Winer KK, Kelly A, Johns A et al (2018) Long-term parathyroid hormone 1-34 replacement therapy in children with hypoparathyroidism. J Pediatr 203:391-399.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2018.08.010","journal-title":"J Pediatr"},{"issue":"2","key":"1582_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-019-02128-z","volume":"67","author":"G Tuli","year":"2020","unstructured":"Tuli G, Buganza R, Tessaris D, Einaudi S, Matarazzo P, De Sanctis L (2020) Teriparatide (rhPTH 1\u201334) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism. Endocrine 67(2):457\u2013465. https:\/\/doi.org\/10.1007\/s12020-019-02128-z","journal-title":"Endocrine"},{"key":"1582_CR19","doi-asserted-by":"publisher","first-page":"764040","DOI":"10.3389\/fped.2021.764040","volume":"9","author":"J Bernardor","year":"2021","unstructured":"Bernardor J, Flammier S, Cabet S et al (2021) Intermittent bi-daily sub-cutaneous teriparatide administration in children with hypoparathyroidism: a single-center experience. Front Pediatr 9:764040. https:\/\/doi.org\/10.3389\/fped.2021.764040","journal-title":"Front Pediatr"},{"issue":"2","key":"1582_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJMc2034981","volume":"385","author":"A Sastre","year":"2021","unstructured":"Sastre A, Valentino K, Hannan FM et al (2021) PTH infusion for seizures in autosomal dominant hypocalcemia type 1. N Engl J Med 385(2):189\u2013191. https:\/\/doi.org\/10.1056\/NEJMc2034981","journal-title":"N Engl J Med"},{"issue":"11","key":"1582_CR21","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1210\/jc.2011-1359","volume":"96","author":"A Linglart","year":"2011","unstructured":"Linglart A, Rothenbuhler A, Gueorgieva I, Lucchini P, Silve C, Bougn\u00e8res P (2011) Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism. J Clin Endocrinol Metab 96(11):3308\u20133312. https:\/\/doi.org\/10.1210\/jc.2011-1359","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1582_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000479867","volume":"89","author":"V Saraff","year":"2018","unstructured":"Saraff V, Rothenbuhler A, H\u00f6gler W, Linglart A (2018) Continuous subcutaneous recombinant parathyroid hormone (1\u201334) infusion in the management of childhood hypoparathyroidism associated with malabsorption. Horm Res Paediatr 89(4):271\u2013277. https:\/\/doi.org\/10.1159\/000479867","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"1582_CR23","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1210\/jc.2005-2605","volume":"91","author":"SD Mittelman","year":"2006","unstructured":"Mittelman SD, Hendy GN, Fefferman RA et al (2006) A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab 91(7):2474\u20132479. https:\/\/doi.org\/10.1210\/jc.2005-2605","journal-title":"J Clin Endocrinol Metab"},{"key":"1582_CR24","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2008.21.4.385","author":"S Sanda","year":"2008","unstructured":"Sanda S, Schlingmann KP, Newfield RS (2008) Autosomal dominant hypoparathyroidism with severe hypomagnesemia and hypocalcemia, successfully treated with recombinant PTH and continuous subcutaneous magnesium infusion. J Pediatr Endocrinol Metab. https:\/\/doi.org\/10.1515\/JPEM.2008.21.4.385","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"1582_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1359\/jbmr.081233","volume":"24","author":"TA Theman","year":"2009","unstructured":"Theman TA, Collins MT, Dempster DW et al (2009) Clinical vignette: PTH(1\u201334) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J Bone Miner Res 24(5):964\u2013973. https:\/\/doi.org\/10.1359\/jbmr.081233","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1582_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5114\/pedm.2020.100402","volume":"27","author":"D Dayal","year":"2021","unstructured":"Dayal D, Panigrahi I, Varma T et al (2021) Ten-year use of recombinant parathyroid hormone for the treatment of hypoparathyroidism in a boy with partial Jacobsen syndrome. Pediatr Endocrinol Diabetes Metab 27(1):57\u201361. https:\/\/doi.org\/10.5114\/pedm.2020.100402","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"1582_CR27","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0005","author":"D Festas Silva","year":"2021","unstructured":"Festas Silva D, De Sousa Lages A, Caetano JS et al (2021) A variant in the CASR gene (c.368T>C) causing hypocalcemia refractory to standard medical therapy. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-21-0005","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"1582_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5863\/1551-6776-27.1.80","volume":"27","author":"ND Bhatt","year":"2022","unstructured":"Bhatt ND, Heh JL, Hudspeth MP, Williams KW, Twombley KE (2022) Teriparatide therapy in a 4-month-old with severe hypoparathyroidism. J Pediatr Pharmacol Ther 27(1):80\u201384. https:\/\/doi.org\/10.5863\/1551-6776-27.1.80","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"6","key":"1582_CR29","doi-asserted-by":"publisher","first-page":"luad136","DOI":"10.1210\/jcemcr\/luad136","volume":"1","author":"F Lindsay Mart","year":"2023","unstructured":"Lindsay Mart F, Winer KK, Johnson K, Wasserman H (2023) Initiation of continuous rhPTH infusion with insulin pump in an inpatient setting. JCEM Case Rep 1(6):luad136. https:\/\/doi.org\/10.1210\/jcemcr\/luad136","journal-title":"JCEM Case Rep"},{"issue":"11","key":"1582_CR30","doi-asserted-by":"publisher","first-page":"luae185","DOI":"10.1210\/jcemcr\/luae185","volume":"2","author":"A Thambundit","year":"2024","unstructured":"Thambundit A, Martinez-Agosto JA, Kianmahd Shamshoni J, Winer KK, Mittelman SD (2024) Three siblings with familial isolated hypoparathyroidism: a diagnostic journey from CASR to novel GCM2 variant. JCEM Case Rep 2(11):luae185. https:\/\/doi.org\/10.1210\/jcemcr\/luae185","journal-title":"JCEM Case Rep"},{"issue":"3","key":"1582_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1210\/clinem\/dgad597","volume":"109","author":"V Pott","year":"2024","unstructured":"Pott V, Tietze H, Kanzelmeyer N et al (2024) LMS-based pediatric reference values for parameters of phosphate homeostasis in the HARP cohort. J Clin Endocrinol Metab 109(3):668\u2013679. https:\/\/doi.org\/10.1210\/clinem\/dgad597","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1582_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/00365513.2011.624631","volume":"72","author":"D Aslan","year":"2012","unstructured":"Aslan D, Andersen MD, Gede LB et al (2012) Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans. Scand J Clin Lab Invest 72(1):14\u201322. https:\/\/doi.org\/10.3109\/00365513.2011.624631","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"1582_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jbmr.4188","volume":"36","author":"A Gilsenan","year":"2020","unstructured":"Gilsenan A, Midkiff K, Harris D, Kellier-Steele N, McSorley D, Andrews EB (2020) Teriparatide Did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study. J Bone Miner Res 36(2):244\u2013251. https:\/\/doi.org\/10.1002\/jbmr.4188","journal-title":"J Bone Miner Res"},{"key":"1582_CR34","unstructured":"U.S. Food and Drug Administration. Teriparatide Drug Label. U.S. Food and Drug Administration; 2025."},{"issue":"4","key":"1582_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/01926230490462138","volume":"32","author":"JL Vahle","year":"2004","unstructured":"Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M (2004) Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose. Toxicol Pathol 32(4):426\u2013438. https:\/\/doi.org\/10.1080\/01926230490462138","journal-title":"Toxicol Pathol"},{"issue":"4","key":"1582_CR36","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s12325-021-01649-2","volume":"38","author":"M Ketteler","year":"2021","unstructured":"Ketteler M, Chen K, Gosmanova EO et al (2021) Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism: a retrospective cohort study. Adv Ther 38(4):1946\u20131957. https:\/\/doi.org\/10.1007\/s12325-021-01649-2","journal-title":"Adv Ther"},{"issue":"4","key":"1582_CR37","doi-asserted-by":"publisher","first-page":"e1215","DOI":"10.1210\/clinem\/dgz319","volume":"105","author":"S Saha","year":"2020","unstructured":"Saha S, Kandasamy D, Sharma R, Bal C, Sreenivas V, Goswami R (2020) Nephrocalcinosis, renal dysfunction, and calculi in patients with primary hypoparathyroidism on long-term conventional therapy. J Clin Endocrinol Metab 105(4):e1215\u2013e1224. https:\/\/doi.org\/10.1210\/clinem\/dgz319","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1582_CR38","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1210\/jc.2015-2257","volume":"100","author":"I Levy","year":"2015","unstructured":"Levy I, Licht C, Daneman A, Sochett E, Harrington J (2015) The impact of hypoparathyroidism treatment on the kidney in children: long-term retrospective follow-up study. J Clin Endocrinol Metab 100(11):4106\u20134113. https:\/\/doi.org\/10.1210\/jc.2015-2257","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1582_CR39","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ejendo\/lvag089","volume":"194","author":"A Vincent","year":"2026","unstructured":"Vincent A, Kamenick\u00fd P, Berkenou J et al (2026) Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment. Eur J Endocrinol 194(5):715\u2013723. https:\/\/doi.org\/10.1093\/ejendo\/lvag089","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1582_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MNH.0000000000000998","volume":"33","author":"H Dimke","year":"2024","unstructured":"Dimke H (2024) New insights into renal calcium-sensing receptor activation. Curr Opin Nephrol Hypertens 33(4):433\u2013440. https:\/\/doi.org\/10.1097\/MNH.0000000000000998","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"1582_CR41","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.autrev.2022.103135","volume":"21","author":"G Bj\u00f8rklund","year":"2022","unstructured":"Bj\u00f8rklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L (2022) Autoimmune polyendocrine syndrome type 1: clinical manifestations, pathogenetic features, and management approach. Autoimmun Rev 21(8):103135. https:\/\/doi.org\/10.1016\/j.autrev.2022.103135","journal-title":"Autoimmun Rev"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01582-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01582-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01582-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T07:09:15Z","timestamp":1784963355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01582-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01582-y","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"120"}}